Pouya Azar

755 total citations
29 papers, 513 citations indexed

About

Pouya Azar is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Toxicology. According to data from OpenAlex, Pouya Azar has authored 29 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Public Health, Environmental and Occupational Health, 21 papers in Anesthesiology and Pain Medicine and 9 papers in Toxicology. Recurrent topics in Pouya Azar's work include Opioid Use Disorder Treatment (26 papers), Pain Management and Opioid Use (20 papers) and Forensic Toxicology and Drug Analysis (9 papers). Pouya Azar is often cited by papers focused on Opioid Use Disorder Treatment (26 papers), Pain Management and Opioid Use (20 papers) and Forensic Toxicology and Drug Analysis (9 papers). Pouya Azar collaborates with scholars based in Canada, United States and Switzerland. Pouya Azar's co-authors include Sukhpreet Klaire, Mohammadali Nikoo, Nickie Mathew, Skye Barbic, Julio Montaner, Paul Nguyen, Evan Wood, M‐J Milloy, Thomas Kerr and Jessica Moe and has published in prestigious journals such as Addiction, Annals of Emergency Medicine and Addictive Behaviors.

In The Last Decade

Pouya Azar

26 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pouya Azar Canada 12 397 241 180 97 91 29 513
Michael A. Yokell United States 10 583 1.5× 113 0.5× 386 2.1× 199 2.1× 74 0.8× 15 735
Emily Behar United States 13 535 1.3× 195 0.8× 303 1.7× 143 1.5× 40 0.4× 18 610
Sophie A. Kitchen Canada 11 288 0.7× 70 0.3× 190 1.1× 68 0.7× 26 0.3× 21 504
Lia Pizzicato United States 9 255 0.6× 46 0.2× 180 1.0× 78 0.8× 60 0.7× 19 416
Marie-Ève Goyer Canada 6 399 1.0× 96 0.4× 269 1.5× 51 0.5× 37 0.4× 11 451
Dana Quesinberry United States 8 342 0.9× 65 0.3× 169 0.9× 156 1.6× 44 0.5× 19 501
Alex Harocopos United States 13 604 1.5× 84 0.3× 565 3.1× 54 0.6× 74 0.8× 32 820
Ashish P. Thakrar United States 13 241 0.6× 98 0.4× 79 0.4× 41 0.4× 64 0.7× 32 397
Amy Sorensen-Alawad United States 6 874 2.2× 204 0.8× 613 3.4× 235 2.4× 98 1.1× 8 988
Payel Roy United States 10 460 1.2× 98 0.4× 354 2.0× 41 0.4× 24 0.3× 23 564

Countries citing papers authored by Pouya Azar

Since Specialization
Citations

This map shows the geographic impact of Pouya Azar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pouya Azar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pouya Azar more than expected).

Fields of papers citing papers by Pouya Azar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pouya Azar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pouya Azar. The network helps show where Pouya Azar may publish in the future.

Co-authorship network of co-authors of Pouya Azar

This figure shows the co-authorship network connecting the top 25 collaborators of Pouya Azar. A scholar is included among the top collaborators of Pouya Azar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pouya Azar. Pouya Azar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, James S.H., Anthony Lau, & Pouya Azar. (2025). Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research. Addiction. 120(11). 2177–2178.
2.
Azar, Pouya, et al.. (2025). Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy. Frontiers in Psychiatry. 16. 1500799–1500799.
3.
Azar, Pouya, Jane J. Kim, Richard Davison, et al.. (2025). Case series: Symptom‐inhibited fentanyl induction (SIFI) onto treatment‐dose opioid agonist therapy in a community setting. American Journal on Addictions. 34(3). 355–360.
4.
Azar, Pouya, et al.. (2025). Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report. Addiction Science & Clinical Practice. 20(1). 42–42. 1 indexed citations
5.
Azar, Pouya, James S.H. Wong, Mohammadali Nikoo, et al.. (2024). Direct Induction of Buprenorphine Extended-Release: A Case Report. Journal of Addiction Medicine. 19(4). 490–493. 1 indexed citations
6.
Tsang, Vivian W. L., James S.H. Wong, Jean N. Westenberg, et al.. (2024). Systematic review on intentional non-medical fentanyl use among people who use drugs. Frontiers in Psychiatry. 15. 1347678–1347678. 10 indexed citations
7.
Kim, Jane J., et al.. (2024). Chronic pain among primary fentanyl users: The concept of self‐medication. European Journal of Pain. 29(1). e4753–e4753. 1 indexed citations
8.
Azar, Pouya, James S.H. Wong, Nickie Mathew, et al.. (2023). 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine. Journal of Addiction Medicine. 18(1). 82–85. 3 indexed citations
9.
Azar, Pouya, James S.H. Wong, Nickie Mathew, et al.. (2022). 48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method. Journal of Addiction Medicine. 17(2). 233–236. 5 indexed citations
10.
Wong, James S.H., Sarah Masson, Alan Huang, et al.. (2022). Cost Analysis of Buprenorphine Extended-Release Injection Versus Sublingual Buprenorphine/Naloxone Tablets in a Correctional Setting. Journal of Correctional Health Care. 28(6). 368–371. 5 indexed citations
11.
Azar, Pouya, Jean N. Westenberg, James S.H. Wong, et al.. (2022). Case report: acute care management of severe opioid withdrawal with IV fentanyl. Addiction Science & Clinical Practice. 17(1). 22–22. 5 indexed citations
12.
Greenwald, Mark K., Andrew A. Herring, Jeanmarie Perrone, Lewis S. Nelson, & Pouya Azar. (2022). A Neuropharmacological Model to Explain Buprenorphine Induction Challenges. Annals of Emergency Medicine. 80(6). 509–524. 33 indexed citations
13.
Wong, James S.H., Mohammadali Nikoo, Jean N. Westenberg, et al.. (2021). Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial. Addiction Science & Clinical Practice. 16(1). 11–11. 28 indexed citations
14.
15.
Moe, Jessica, et al.. (2020). Microdosing and standard‐dosing take‐home buprenorphine from the emergency department: A feasibility study. Journal of the American College of Emergency Physicians Open. 1(6). 1712–1722. 29 indexed citations
16.
Moe, Jessica, Mary M. Doyle‐Waters, Fiona O’Sullivan, Corinne M. Hohl, & Pouya Azar. (2020). Effectiveness of micro-induction approaches to buprenorphine initiation: A systematic review protocol. Addictive Behaviors. 111. 106551–106551. 8 indexed citations
17.
Moe, Jessica, Fiona O’Sullivan, Corinne M. Hohl, et al.. (2020). Short communication: Systematic review on effectiveness of micro-induction approaches to buprenorphine initiation. Addictive Behaviors. 114. 106740–106740. 39 indexed citations
18.
Barbic, Skye, Ian Manion, Emily Jenkins, et al.. (2019). Understanding the mental health and recovery needs of Canadian youth with mental health disorders: a Strategy for Patient-Oriented Research (SPOR) collaboration protocol. International Journal of Mental Health Systems. 13(1). 6–6. 22 indexed citations
19.
Klaire, Sukhpreet, et al.. (2019). Rapid Micro‐Induction of Buprenorphine/Naloxone for Opioid Use Disorder in an Inpatient Setting: A Case Series. American Journal on Addictions. 28(4). 262–265. 79 indexed citations
20.
Azar, Pouya, Evan Wood, Paul Nguyen, et al.. (2015). Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BMC Infectious Diseases. 15(1). 193–193. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Yokell Breakdown of academic impact, for papers by Emily Behar Breakdown of academic impact, for papers by Sophie A. Kitchen Breakdown of academic impact, for papers by Lia Pizzicato Breakdown of academic impact, for papers by Marie-Ève Goyer Breakdown of academic impact, for papers by Dana Quesinberry Breakdown of academic impact, for papers by Alex Harocopos Breakdown of academic impact, for papers by Ashish P. Thakrar Breakdown of academic impact, for papers by Amy Sorensen-Alawad Breakdown of academic impact, for papers by Payel Roy
Rankless by CCL
2026